Literature DB >> 6341004

The anaemia of Plasmodium falciparum malaria.

D J Weatherall, S Abdalla, M J Pippard.   

Abstract

Anemia is an important complication of P. falciparum malaria infection. This paper describes recent studies that have attempted to define some of the pathophysiological mechanisms involved in different forms of infection and at different stages of the illness. After an acute infection there is a steady fall in the haemoglobin level with an inappropriate reticulocyte response. Current evidence indicates that this form of anaemia may result from a combination of acute sequestration of iron in the reticuloendothelial system associated with a shortened red cell survival. Recent studies indicate that there may be a dyserythropietic component as well. The mechanism for the shortened red cell survival is uncertain; although it may be due in part to sequestration of parasitized cells, the haemoglobin level continues to fall for several weeks after the acute episode and other factors must be involved. The role of immune haemolysis appears to be relatively small. It is becoming apparent that severe dyserythropoiesis with minimal haemolysis plays a major role in the anaemias of Plasmodium falciparum infection, particularly in immune individuals. This phenomenon has been studied by both light and electron microscopy and by assessing the in vitro kinetics of erythroid precursor proliferation. The results indicate a major defect in erythroid maturation with a significant degree of erythrophagocytosis. Although these studies have provided a clearer picture of the pathophysiology of anaemia at different phases of P. falciparum infection, there is still little indication of how the basic changes in red cell production and survival are mediated.

Entities:  

Mesh:

Year:  1983        PMID: 6341004     DOI: 10.1002/9780470715444.ch6

Source DB:  PubMed          Journal:  Ciba Found Symp        ISSN: 0300-5208


  7 in total

1.  Oxidative damage of erythrocytes infected with Plasmodium falciparum. An in vitro study.

Authors:  K Mohan; N K Ganguly; M L Dubey; R C Mahajan
Journal:  Ann Hematol       Date:  1992-09       Impact factor: 3.673

Review 2.  Malaria-related anaemia: a Latin American perspective.

Authors:  Juan Pablo Quintero; André Machado Siqueira; Alberto Tobón; Silvia Blair; Alberto Moreno; Myriam Arévalo-Herrera; Marcus Vinícius Guimarães Lacerda; Sócrates Herrera Valencia
Journal:  Mem Inst Oswaldo Cruz       Date:  2011-08       Impact factor: 2.743

3.  Macrophage migration inhibitory factor release by macrophages after ingestion of Plasmodium chabaudi-infected erythrocytes: possible role in the pathogenesis of malarial anemia.

Authors:  J A Martiney; B Sherry; C N Metz; M Espinoza; A S Ferrer; T Calandra; H E Broxmeyer; R Bucala
Journal:  Infect Immun       Date:  2000-04       Impact factor: 3.441

4.  An Atypical Splenic B Cell Progenitor Population Supports Antibody Production during Plasmodium Infection in Mice.

Authors:  Debopam Ghosh; Daniel J Wikenheiser; Brian Kennedy; Kathryn E McGovern; Johnasha D Stuart; Emma H Wilson; Jason S Stumhofer
Journal:  J Immunol       Date:  2016-07-22       Impact factor: 5.422

5.  Alterations of uninfected red blood cells in malaria.

Authors:  D Sabolovic; J C Bouanga; M Danis; D Mazier; M Gentilini
Journal:  Parasitol Res       Date:  1994       Impact factor: 2.289

6.  Membrane stability of sickle erythrocytes incubated in extracts of three medicinal plants: Anacardium occidentale, Psidium guajava, and Terminalia catappa.

Authors:  Paul Chidoka Chikezie; Augustine Amadikwa Uwakwe
Journal:  Pharmacogn Mag       Date:  2011-04       Impact factor: 1.085

7.  A murine model of falciparum-malaria by in vivo selection of competent strains in non-myelodepleted mice engrafted with human erythrocytes.

Authors:  Iñigo Angulo-Barturen; María Belén Jiménez-Díaz; Teresa Mulet; Joaquín Rullas; Esperanza Herreros; Santiago Ferrer; Elena Jiménez; Alfonso Mendoza; Javier Regadera; Philip J Rosenthal; Ian Bathurst; David L Pompliano; Federico Gómez de las Heras; Domingo Gargallo-Viola
Journal:  PLoS One       Date:  2008-05-21       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.